About Peter Matlawa

This author has not yet filled in any details.
So far Peter Matlawa has created 438 blog entries.

A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV.

Ndlangisa KM, du Plessis M, Lo S, de Gouveia L, [...]

By |2023-04-12T15:00:43+02:00April 12, 2023|2022: April to June|Comments Off on A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV.

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.

Ndjeka N, Campbell JR, Meintjes G, Maartens G, Schaaf HS, [...]

By |2023-04-12T14:53:20+02:00April 12, 2023|2022: April to June|Comments Off on Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.

Molecular type distribution and fluconazole susceptibility of clinical Cryptococcus gattii isolates from South African laboratory-based surveillance, 2005-2013.

Naicker SD, Firacative C, van Schalkwyk E, Maphanga TG, Monroy-Nieto [...]

By |2023-04-12T14:49:39+02:00April 12, 2023|2022: April to June|Comments Off on Molecular type distribution and fluconazole susceptibility of clinical Cryptococcus gattii isolates from South African laboratory-based surveillance, 2005-2013.
Go to Top